Alex Dodoo
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 6
-
- Pharmaceutical Quality and Counterfeiting 4
- Co-authors
- Sten Olsson (2 shared papers)Shanthi Pal (2 shared papers)Mahama Duwiejua (1 shared paper)Lloyd Matowe (1 shared paper)Hannes Enlund (1 shared paper)Martin Danis (1 shared paper)Patrick Imbert (1 shared paper)Fabrice Legros (1 shared paper)
- Journals
- Malaria Journal (3 papers)Expert Opinion on Drug Safety (1 paper)PLoS Medicine (1 paper)Drug Safety (1 paper)Vaccine (1 paper)
- Partner nations
- GhanaSwitzerlandUnited States
In The Last Decade
Alex Dodoo
14 papers receiving 382 citations
Peers
Comparison fields: 5 of 86
- Toxicology 131
- Applied Microbiology and Biotechnology 22
- Health 78
- Geriatrics and Gerontology 31
- Infectious Diseases 91
Countries citing papers authored by Alex Dodoo
This map shows the geographic impact of Alex Dodoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Dodoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Dodoo more than expected).
Fields of papers citing papers by Alex Dodoo
This network shows the impact of papers produced by Alex Dodoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Dodoo. The network helps show where Alex Dodoo may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Dodoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 103 | |
| 2 | 2004 | 60 | |
| 3 | 2007 | 52 | |
| 4 | 2009 | 48 | |
| 5 | 2011 | 30 | |
| 6 | 2018 | 28 | |
| 7 | 2019 | 23 | |
| 8 | 2008 | 17 | |
| 9 | 2011 | 16 | |
| 10 | 2015 | 11 | |
| 11 | 2015 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 2 | |
| 14 | 2007 | 1 |
About Alex Dodoo
Alex Dodoo is a scholar working on Toxicology, Public Health, Environmental and Occupational Health, Economics and Econometrics, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 14 papers that have together received 406 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Pharmaceutical Economics and Policy (5 papers), Pharmaceutical Quality and Counterfeiting (4 papers), Vaccine Coverage and Hesitancy (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Influenza Virus Research Studies (2 papers), Pharmaceutical studies and practices (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Toxicology (131 citations), Applied Microbiology and Biotechnology (22 citations), Health (78 citations), Geriatrics and Gerontology (31 citations) and Infectious Diseases (91 citations). Alex Dodoo has collaborated with scholars based in Ghana, Switzerland and United States. Frequent co-authors include Sten Olsson, Shanthi Pal, Mahama Duwiejua, Lloyd Matowe, Hannes Enlund, Martin Danis, Patrick Imbert, Fabrice Legros, Olivier Bouchaud and C. Burri. Their work appears in journals such as Malaria Journal, Expert Opinion on Drug Safety, PLoS Medicine, Drug Safety and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.